|

Leucovorin (Calcium Folinate) Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 3: 2

Top Sponsors

  • Revolution Medicines, Inc.1
  • Genmab1

Indications

  • Cancer2
  • Pancreatic Adenosquamous Carcinoma1
  • PDAC1
  • Pancreatic Adenocarcinoma Metastatic1
  • Pancreatic Cancer Metastatic1

Other1 trial

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
Phase 3

Tucson, Arizona1 trial

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

The University of Arizona Cancer Center-North Campus

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.